Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Review ArticleSpecial Issue Commemorating the 50th Anniversary of Molecular Pharmacology

The First 50 Years of Molecular Pharmacology

Joan Heller Brown, William A. Catterall, P. Jeffrey Conn, Stuart G. Cull-Candy, Ray Dingledine, T. Kendall Harden, Paul A. Insel, Graeme Milligan and Stephen F. Traynelis
Molecular Pharmacology July 2015, 88 (1) 139-140; DOI: https://doi.org/10.1124/mol.115.099564
Joan Heller Brown
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William A. Catterall
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Jeffrey Conn
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart G. Cull-Candy
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stuart G. Cull-Candy
Ray Dingledine
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Kendall Harden
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. Insel
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme Milligan
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Graeme Milligan
Stephen F. Traynelis
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California (J.H.B., P.A.I.); Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C.); Department of Neuroscience, Physiology, and Pharmacology, University College London, London, United Kingdom (S.G.C.-C.); Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (R.D., S.F.T.); Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.H.); and Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen F. Traynelis
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Visual Overview

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract

In this Perspective, former and current editors of Molecular Pharmacology, together with the guest editors for this 50th Anniversary Issue, provide a historical overview of the journal since its founding in 1965. The substantial impact that Molecular Pharmacology has had on the field of pharmacology as well as on biomedical science is discussed, as is the broad scope of the journal. The authors conclude that, true to the original goals for the journal, Molecular Pharmacology today remains an outstanding venue for work that provides a mechanistic understanding of drugs, molecular probes, and their biologic targets.

Footnotes

    • Received April 17, 2015.
    • Accepted May 5, 2015.
  • dx.doi.org/10.1124/mol.115.099564.

  • Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 88 (1)
Molecular Pharmacology
Vol. 88, Issue 1
1 Jul 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The First 50 Years of Molecular Pharmacology
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleSpecial Issue Commemorating the 50th Anniversary of Molecular Pharmacology

The First 50 Years of Molecular Pharmacology

Joan Heller Brown, William A. Catterall, P. Jeffrey Conn, Stuart G. Cull-Candy, Ray Dingledine, T. Kendall Harden, Paul A. Insel, Graeme Milligan and Stephen F. Traynelis
Molecular Pharmacology July 1, 2015, 88 (1) 139-140; DOI: https://doi.org/10.1124/mol.115.099564

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Review ArticleSpecial Issue Commemorating the 50th Anniversary of Molecular Pharmacology

The First 50 Years of Molecular Pharmacology

Joan Heller Brown, William A. Catterall, P. Jeffrey Conn, Stuart G. Cull-Candy, Ray Dingledine, T. Kendall Harden, Paul A. Insel, Graeme Milligan and Stephen F. Traynelis
Molecular Pharmacology July 1, 2015, 88 (1) 139-140; DOI: https://doi.org/10.1124/mol.115.099564
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Assessing GPCR Expression in Native Cells
  • Drug Receptor Sites on Sodium and Calcium Channels
Show more Special Issue Commemorating the 50th Anniversary of Molecular Pharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics